Clinical Trials on Pilonidal Sinus Treatment in Finland

Total 67 results

Niuvanniemi Hospital

Active, not recruiting

Navigated αTMS in Treatment-resistant Schizophrenia (nTMS_NS)

Schizophrenia | Schizoaffective Disorder

Finland
Tampere University

Completed

Effectiveness of Narrative Exposure Therapy Among Refugee Children and Adolescents

Treatment as Usual | Narrative Exposure Therapy

Finland
Kuopio University Hospital
University of Eastern Finland

Recruiting

Portable Measurement Methods Combined With Artificial Intelligence in Detection of Atrial Fibrillation (WB-AF)

Atrial Fibrillation | Heart Rate Fast | Heart Rate Low | Sinus Rhythm

Finland
Kuopio University Hospital

Completed

Postoperative Treatment After Endoscopic Sinus Surgery

Sinusitis

Finland
Turku University Hospital

Unknown

Serum Biomarker HE4 During IVF Treatment (FHE4)

IVF Treatment | Human Epididymal Secretory Protein E4

Finland
Joint Authority for Päijät-Häme Social and Health...
Kanta-Häme Central Hospital

Recruiting

Laparoscopic Approach for Emergency Colon Resection

Laparoscopic Surgery | Emergencies | Colorectal Cancer | Colorectal Disorders | Complication of Surgical Procedure | Long-term Effects of Cancer Treatment

Finland
University of California, San Francisco
Kenya Medical Research Institute; Organic Health Response; Microclinic International

Completed

Healthy Networks Water Treatment Study (HNWT)

Household Water Treatment | Waterborne Illness

Kenya
Butler Hospital
National Institute of General Medical Sciences (NIGMS)

Recruiting

Exercise to Augment TMS in Those With Treatment Resistant Depression

Treatment Resistant Depression

United States
Tampere University Hospital

Active, not recruiting

The Causal Relation of Nasal Nitric Oxide Levels to the Severity of Chronic Rhinosinusitis and Its Inflammatory Phenotype

Chronic Rhinosinusitis (Diagnosis)

Finland
Tampere University Hospital

Recruiting

Balloon Sinuplasty Efficiency in Maxillary Rhinosinusitis.

Maxillary Sinusitis | Eustachian Tube Dysfunction | Sinusitis, Chronic | Sinusitis Recurrent

Finland
Oulu University Hospital
Tampere University Hospital

Recruiting

Endoscopic Sinus Surgery in Recurrent Acute Rhinosinusitis

Sinusitis | Maxillary Sinusitis | Sinusitis, Acute

Finland
Medtronic BRC

Unknown

Efficacy of a Pacemaker Algorithm in Promotion of the Intrinsic Heart Activity.

Bradycardia; Sick Sinus Syndrome, AV Block

Germany, Denmark, Netherlands, Austria, Czech Republic, United Kingdom, Sweden, Finland, Italy, Russian Federation, Switzerland
Massachusetts General Hospital
National Institute of Mental Health (NIMH); Temple University; Butler Hospital; University of Kansas and other collaborators

Terminated

Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression (RAPID KOR)

Treatment Resistant Depression

United States
MedtronicNeuro

Completed

Reclaim Deep Brain Stimulation Clinical Study for Treatment-Resistant Depression

Depression

United States
Rhode Island Hospital

Completed

A Pilot Gaming Adherence Program for Youth Living With HIV

Adherence to HIV Treatment and Medication

United States
Oulu University Hospital

Unknown

Middle Meatal Bacteriology During Acute Respiratory Infection in Children

Sinusitis | Acute Respiratory Infection

Finland
Rhode Island Hospital

Recruiting

Family Navigator Intervention

Treatment as Usual | Family Navigator

United States
Helsinki University Central Hospital

Active, not recruiting

Aggravated Airway Inflammation: Research on Genomics and Optimal Operative Treatment (AirGOs Operative)

Asthma | Nasal Polyps | Aspirin Sensitivity | Sinusitis, Chronic

Finland, Netherlands
Janssen Research & Development, LLC

Completed

A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression (SUSTAIN-2)

Treatment-resistant Depression

United States, Australia, France, United Kingdom, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Poland, Bulgaria, Malaysia, South Africa, Turkey, Finland, Korea, Republic of, Brazil, Austria, Sweden, Lithuania
Cyberonics, Inc.

Completed

Study Comparing Outcomes for Patients With Treatment Resistant Depression Who Receive VNS Therapy at Different Doses

Depression

United States
Boston Scientific Corporation

Completed

Safety and Performance Study of the INGEVITY Lead

Bradycardia | Sinus Node Dysfunction

United States, Belgium, Germany, Canada, Spain, Sweden, Italy, Malaysia, Denmark, Australia, Austria, United Kingdom, Hong Kong, France, Portugal, Thailand
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression (TRANSFORM-1)

Treatment-resistant Depression

United States, France, Belgium, Mexico, Canada, Brazil, Estonia, Hungary, Slovakia
Rhode Island Hospital
National Institute on Drug Abuse (NIDA)

Completed

Digital Health Intervention to Support Opioid Use Disorder Treatment (iENDURE)

Opioid Use Disorder | Treatment Adherence

United States
LivaNova

Active, not recruiting

The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes (UNCOVER)

Treatment Resistant Depression

United States
Axsome Therapeutics, Inc.

Completed

Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)

Major Depressive Disorder | Treatment Resistant Depression

United States
Axsome Therapeutics, Inc.

Completed

Mechanistic Evaluation of Response in TRD (MERIT) (MERIT)

Major Depressive Disorder | Treatment Resistant Depression

United States
LivaNova

Recruiting

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER)

Treatment Resistant Depression

United States
COMPASS Pathways

Recruiting

Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

Treatment Resistant Depression

United States, Spain, Ireland, France, United Kingdom, Canada, Sweden
Merck Sharp & Dohme LLC

Terminated

Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)

Treatment Resistant Depression

United States
Lifespan
National Institute on Drug Abuse (NIDA)

Recruiting

Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: Qualitative Interviews

Opioid Use Disorder | Treatment Adherence and Compliance | Criminal Justice

United States
Medtronic Cardiac Rhythm and Heart Failure

Completed

The Atrial High Rate Episodes in Pacemaker Patients

Atrial Fibrillation | Bradycardia | Arrhythmia | Atrioventricular Block | Sick Sinus Syndrome

France, United States, Australia
Eli Lilly and Company

Completed

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

Major Depressive Disorder

United States, Canada
Eli Lilly and Company

Completed

A Study in Relapse Prevention of Treatment-Resistant Depression

Treatment Resistant Depression

United States, Argentina, Russian Federation, South Africa, India, Turkey, Puerto Rico, Mexico
Change Accelerator in Respiratory Care

Recruiting

Real-Life Chronic Rhinosinusitis Outcome Registry

Chronic Rhinosinusitis (Diagnosis)

Belgium, Denmark, Spain, France, Finland, Italy, Austria, United Kingdom, Netherlands, Germany
Medtronic

Recruiting

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products (PPR)

Heart Failure | Bradycardia | Arrhythmia | Sinus Tachycardia

China, France, Spain, United States, Australia, Belgium, Canada, Czechia, Denmark, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Norway, Poland, Portugal, Saudi Arabia, Serbia, Sweden, Switze... and more
Axsome Therapeutics, Inc.

Completed

Open-Label Safety Study of AXS-05 in Subjects With Depression

Depression | Major Depressive Disorder | Treatment Resistant Depression

United States
Cyberonics, Inc.

Completed

Treatment-Resistant Depression Registry

Major Depressive Disorder

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression (TRANSFORM-3)

Depressive Disorder, Treatment-Resistant

United States, France, Belgium, Spain, Poland, Bulgaria, South Africa, Finland, Brazil, Sweden, United Kingdom, Lithuania
Janssen Research & Development, LLC

Completed

A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression

Depressive Disorder, Treatment-Resistant

United States
Janssen Research & Development, LLC

Completed

A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression (SUSTAIN-3)

Depressive Disorder, Treatment-Resistant

United States, France, Poland, United Kingdom, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Bulgaria, Malaysia, South Africa, Turkey, Canada, Korea, Republic of, Brazil, Estonia, Hungary, Lithuania, Slovakia, Sweden, Czechia, A... and more
Avanir Pharmaceuticals

Completed

Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

Depressive Disorder, Treatment-Resistant

United States
ACADIA Pharmaceuticals Inc.

Terminated

Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Adjunctive Treatment of Major Depressive Disorder

United States, Serbia, Finland, Poland, Russian Federation, Slovakia, South Africa, Ukraine, United Kingdom
ACADIA Pharmaceuticals Inc.

Completed

Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)

Adjunctive Treatment of Major Depressive Disorder

United States
Southwest Oncology Group
National Cancer Institute (NCI); Cancer and Leukemia Group B

Completed

SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease

Lymphoma | Psychosocial Effects of Cancer and Its Treatment

United States
ACADIA Pharmaceuticals Inc.

Completed

Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Adjunctive Treatment of Major Depressive Disorder

United States, Serbia, Finland, Poland, Russian Federation, Ukraine, United Kingdom, Slovakia, South Africa
Clexio Biosciences Ltd.

Completed

A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study

Adjunctive Treatment of Major Depressive Disorder

United States, Puerto Rico
Axsome Therapeutics, Inc.

Completed

A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder (STRIDE-1)

Treatment Resistant Major Depressive Disorder

United States
GlaxoSmithKline

Completed

ARTS - AVODART After Radical Therapy For Prostate Cancer Study (ARTS)

Neoplasms, Prostate | Prostate Cancer After a Radical Treatment

Spain, Estonia, Netherlands, United Kingdom, Germany, Finland, France, Russian Federation, Sweden
Pfizer

Completed

Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

Migraine | Acute Treatment of Migraine

United States
Amgen

Completed

A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.

Treatment for Prevention of Chronic Migraine

United States, United Kingdom, Poland, Germany, Czechia, Sweden, Canada, Denmark, Finland, Norway

Clinical Trials on Pilonidal Sinus Treatment in Finland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations